Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sequenom launches bid to acquire Exact Sciences; withdrawn

Executive Summary

Genetic analysis company Sequenom has launched a hostile takeover of Exact Sciences (cancer diagnostics). Sequenom's initial all-stock bid of $1.50 in Sequenom shares per Exact share (a 138% premium over Exact's trading average; valuing the deal at about $41mm) was immediately rejected by Exact's board of directors.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register